INTRODUCTION
The strong demand for transparency in health care outcomes is leading to increasing comparison of hospital performances. The strongest and most acknowledged performance indicator is undoubtedly postoperative mortality. Higher mortality rates have traditionally been thought to be the consequence of higher complication rates. Recent studies, however, suggested that not the occurrence of a complication but its treatment drives differences in mortality. Failure to rescue (FTR), first described by Silber et al., is defined as the death of a patient due to a major postoperative complication. 1, 2 FTR has shown to be more responsible for differences in mortality rates between hospitals following various surgical procedures, compared to differences in complication rates. [3] [4] [5] [6] [7] [8] FTR is an indicator of the management of complications and may distinguish a high-mortality from a low-mortality hospital. The association of various factors with the occurrence of FTR has therefore been investigated and includes mainly hospital structural factors such as patient volume, staffing levels, and technology status. 7, [9] [10] [11] FTR is especially a relevant topic in pancreatic surgery, as pancreatic surgery remains associated with high complication rates of around 50% and major complication rates up to 30%. 12, 13 Nationwide analyses of FTR in pancreatic surgery are however lacking.
In 2013, the Dutch Pancreatic Cancer Audit (DPCA) was launched. Registration of patients undergoing pancreatic surgery in the DPCA is mandatory for the Dutch pancreatic centers, each of who performs at least 20 pancreatoduodenectomies (PDs) annually. Our objective was to compare major complication and FTR rates between hospitals with high and low mortality after PD. The second objective was to develop a prognostic model to predict FTR.
METHODS

Patients and methods
Under Dutch law, no Institutional Review Board (IRB) approval or informed consent was required for this study. All patients undergoing PD for a (suspected) pancreatic-or periampullary neoplasm between January 1st 2014, and December 31st 2015, who were registered in the DPCAwere included. All 18 pancreatic centers in the Netherlands participate in the audit, each performing a minimum of 20 PDs annually. The DPCA has demonstrated over 90% case ascertainment and over 95% data accuracy.
14 Scatterplots with regressions analyses were used to investigate the correlation between mortality, major complications, and FTR. Additionally, hospitals were grouped into quartiles of hospitals 10 166 CHAPTER 10 based on mortality rates. The rates of major complications and FTR were compared between these groups. The incidence of specific complications in patients with FTR was also assessed between the quartiles. Regression analysis was used to explore the association of FTR with patient and tumor characteristics, and hospital volume.
Data collection
Within the DPCA a wide range of anonymized clinicopathological variables, and outcomes are prospectively collected. 
RESULTS
Patients and outcomes
In total, 1342 patients undergoing PD were included. Over half of patients were male (57%) with a mean age of 66 (SD 11) years. In-hospital mortality was 4.2%. Histopathological diagnosis was pancreatic ductal adenocarcinoma in 560 (42%) patients, and periampullary (distal bile duct, duodenum, ampulla) carcinoma in 432 (32%) patients (Table 1) .
A total of 889 (66.2%) patients experienced a complication whereas 391 (29.1%) patients experienced a major complication. A total of 56 patients died after a major complication, corresponding to a FTR rate of 14.3% (56/391). In total, 182 (13.6%) patients had a grade B/C POPF, 127 (9.5%) a grade B/C PPH, and 239 (17.8%) patients a grade B/C DGE. 
CHAPTER 10
Variation between hospitals
Between hospitals, the mortality rate varied from 0% to 13.2%. Whereas a strong correlation between mortality and FTR was found (r = 0.84, p < 0.001, Fig. 1a) , the correlation between mortality and major complications was weaker (r = 0.47, p < 0.001, Fig. 1b ).
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FAILURE TO RESCUE Fig. 2 demonstrates the variation in mortality, major complication rate, and FTR between the hospital quartiles based on mortality. In the first quartile (with the lowest mortality), the average mortality rate was 0.9%, whereas this was 8.1% in the fourth quartile. The rate of major complications increased by 40% between the first and the fourth quartile (25.7%-35.2%), whereas the FTR increased by 560% between the first and fourth quartile (3.6%-22.9%) (see Fig. 3 ).
There were no significant differences between the quartiles in the incidence of CR-POPF, CR-PPH, CR-DGE or CR-BL in patients who died with a major complication. The incidence of patients who died with a major complication and CR-POPF was 0% (0 out of 3) in the first hospital quartile (with the lowest mortality), 18.2% (2 out of 11) in the second quartile, 41.2% ( All independent prognostic factors were included in the nomogram (Fig. 3) . Outcomes of multivariable analysis with categorized values of age and BMI are available in the Supplementary 
DISCUSSION
This nationwide study shows striking differences in major complication and FTR rates between hospitals with high and low mortality after PD. Varying mortality rates between hospitals seemed to be explained to a much larger extent by varying FTR, than by varying complication rates. This was clearly illustrated by the 560% increase in FTR between the first and fourth hospital mortality quartile, compared to a 40% increased rate of major complications between these quartiles. Higher volume centers (at least 40 PDs annually) displayed the lowest FTR rates compared to lower volume hospitals. A nomogram was able to stratify patients into very low (2%), low (4%), and high (12%) FTR risk based on both patient and hospital characteristics.
This study uses data from a mandatory nationwide audit on pancreatic surgery to study FTR and only reports on patients undergoing PD. This audit contains more than 150 variables per patient, each with strict data definitions and extensive registration of clinicopathological characteristics.
Previous studies investigating FTR, 3, 4, 7, 9, 22, 23 used large scale administrative datasets which are known to be hampered by inaccurate registration of (the severity of) complications. 24, 25 Previous studies on FTR have focused on high-risk surgery including pancreatic resections of all typesincluding both PD and distal pancreatectomy, with known differences in outcome. 3, 4, 7, 9, 22, 23 The magnitude of increase in FTR was 560% in the current study as compared to 525% and 1150%
in two previous studies investigating FTR among patients undergoing pancreatic resection (all types). 3, 9 Contrary to previous studies we were able to include patients of all ages 3, 7, 23 and included all nationwide pancreatic centers instead of only dedicated participating centers. Most reports on mortality rates after PD originate from individual, high-volume, expert centers.
Studies on a national level usually report higher mortality rates. Nationwide in-hospital mortality found in the present study (4.2%) seems lower compared to other recent nationwide reports e.g. from the U.S. (6-7%) and Italy (8.1%). [26] [27] [28] A recent nationwide study from Germany reported a 7.7% in-hospital mortality rate after PD. 29 The rate of major complications (29%) found in this study is comparable to reports from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP). The identification of FTR as a key explanation for varying mortality rates after PD between hospitals has important implications for clinical practice and future research. Clinical research has focused mainly on the prevention of complications. Future studies should focus on strategies to improve early detection and management of major complications, including differences in infrastructure between centers (e.g. interventional radiology, nurse to patient ratio). In previous investigations, escalation of care has been proposed to reduce FTR by "the recognition and communication of patient deterioration to a senior colleague". 11, 32, 33 Factors that may hamper escalation of care include lack of established protocol or support of team members, hierarchy, and understaffing.
Improvements in each item may lead to better outcomes.
Several previous studies have identified lower hospital volume as a risk factor for FTR. because were constrained to the data registered in the DPCA, we could not study which specific aspects of complication management (e.g. screening for complications, timing of intervention, type of intervention) in high-volume hospitals were responsible for the observed lower FTR rates.
Future studies should evaluate whether hospital volume is associated with better escalation of care.
Surgical experience is only one factor for escalation of care. Experience of the whole team (e.g. the night nurse, the resident on call, the interventional radiologist) involved in the care for a patient with a major complication after a PD is equally important. In high-volume hospitals all members of the team may be more experienced in recognizing and treating complications after PD. Detailed clinical pathways for detection and management major complications after PD may have the potential to reduce FTR in both low-and high-volume hospitals but this concept needs to be tested in future prospective studies. 34 Furthermore, in the present study there were no significant differences in the incidence of (grade B/C) procedure related complications between the quartiles in patients who died with a major complication. However, there was a large increase in the incidence of CR-POPF across the hospital quartiles in patients who died with a major complication: 0% in the first hospital quartile (with the lowest mortality), and 56% in the fourth hospital quartile. Unfortunately, we were limited by relatively low event sizes and due to the design of the audit cannot determine if specific interventions were performed for POPF. Future studies should investigate the effect of differences in treatment strategies for POPF on FTR. For example, complication management is increasingly shifting towards non-operative interventions and therefore, away from the surgeon. 35 Other factors such as hospital technology or teaching status, number of hospital beds, level of ICU, average daily census, nurse-to-patient ratio, or patient co-morbidities could also be associated with variation in FTR. 7, 9, 10, 36 Contrary to previous studies, in our study hospital teaching status was not related to FTR. 7, 9 This can probably be explained by the centralization of pancreatic surgery in the Netherlands, which has been accompanied by a significant decrease in postoperative mortality (9.8%-5.1% between 2004 and 2009). 37 Prior to centralization, university hospitals in the Netherlands demonstrated better outcomes compared to non-university hospitals. 38 Our study has some limitations. We were not able to determine the primary cause of patients'
death. Therefore, we cannot indisputably claim that higher mortality is caused by worse FTR.
However, the vast majority of mortality after PD is caused by procedure related complications. 12 Furthermore, the series of events following a major complication often obscures the primary cause of death. 39 Some variation in the incidence of major complications between the mortality quartiles may be explained by differences in strategies in case of DGE (the most common complication after PD). However, in a sensitivity analysis excluding all patients with DGE as the only major complication, the results did not change. Due to the design of the audit we were not able to determine the number of complications per patient. Therefore, it is possible that in the highest hospital quartiles of mortality, there were relatively more patients with more than one complication. Differences in mortality could then also be attributed to more (procedure related) complications in some patients.
However, we were able to determine the number of patients with more than one procedure specific major complication, i.e. POPF, PPH, DGE and BL. This was limited to less than 10% of patients, and the distribution was not significantly different between the hospital quartiles.
This study has several strengths compared to previous studies. The DPCA includes all 18 pancreatic centers in the Netherlands, all of whom are high volume by the definition of 20 PDs per year, and therefore allows evaluation of FTR on a national level. This eliminates the selection bias seen in previous studies. 3, 4, 7, 9, 22, 23, 40 Furthermore, the DPCA does not rely on administrative data assuring correct coding of procedures, complications, and severity grading.
In conclusion, variation in hospital mortality after PD on a nationwide level is probably explained to a much larger extent by differences in FTR rather than complication rates. 
